EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Challenges around diagnosis of early onset colorectal cancer, and the case for screening

Oliver Waddell iD, Jacqueline Keenan, Frank Frizelle

ANZ Journal of Surgery · 2024-10 · 94 (10) · 1687-1692

DOI: 10.1111/ans.19221 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ANZ Journal of Surgery, online erschienen am 29.08.2024. Verfasst von Oliver Waddell und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Critical Care, University of Otago Christchurch, Christchurch, New Zealand. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) is the third most diagnosed cancer in the world, with an estimated 1.93 million cases diagnosed in 2020. While the overall CRC incidence in many countries is falling there has been a dramatic increase in CRC in those aged under 50 (early onset colorectal cancer, EOCRC). The reason for this increase in EOCRC is unknown. As the best predictor of survival is stage at diagnosis, early diagnosis is likely to be beneficial and population screening may facilitate this.

Methods

A narrative review of the literature was undertaken.

Results

Improving time to diagnosis in symptomatic patients is beneficial. However, by the time symptoms develop, over a third of patients already have metastatic disease. Screening asymptomatic patients (with Faecal Immunochemical test (FIT) and colonoscopy) has been proved to be effective in older patients (>60 years). In younger populations, the decreasing incidence rates of CRC previously made cost effectiveness, compliance and therefore benefit questionable. Now, with the increasing incidence of CRC in those under 50 years of age, modelling suggests screening with FIT and colonoscopy is cost effective from 40 years of age. There is evidence that some countries screening below 50 have prevented the rise in EOCRC incidence. Additionally the use of new and novel non‐invasive biomarkers may also be able to improve the accuracy of screening asymptomatic patients.

Conclusion

Diagnosis of EOCRC once symptoms develop is often too late, and screening patients from age 40 is the best way to improve outcomes in this group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEarly Detection of CancerHumansColonoscopyAge of OnsetIncidenceMass ScreeningOccult BloodMiddle AgedCost-Benefit Analysis

Stichwörter der Autor:innen

Colorectal surgeryEarly onset colorectal cancerScreeninggeneral surgery

Autor:innen und Institutionen

  • Department of Surgery and Critical Care, University of Otago Christchurch, Christchurch, New Zealand.
  • Department of General Surgery, Te Whatu Ora Health New Zealand, Christchurch, New Zealand.

ORCID-Profile: Oliver Waddell

Zitieren

APA

Waddell, O., Keenan, J., & Frizelle, F. (2024). Challenges around diagnosis of early onset colorectal cancer, and the case for screening. ANZ Journal of Surgery, 94(10), 1687-1692. https://doi.org/10.1111/ans.19221

Vancouver

Waddell O, Keenan J, Frizelle F. Challenges around diagnosis of early onset colorectal cancer, and the case for screening. ANZ Journal of Surgery. 2024;94(10):1687-1692. doi:10.1111/ans.19221

BibTeX
@article{Waddell2024,
  author = {Waddell, Oliver and Keenan, Jacqueline and Frizelle, Frank},
  title = {Challenges around diagnosis of early onset colorectal cancer, and the case for screening},
  journal = {ANZ Journal of Surgery},
  year = {2024},
  volume = {94},
  number = {10},
  pages = {1687--1692},
  doi = {10.1111/ans.19221}
}
Kostenlos starten →